Semler Scientific, a medical device firm, made headlines recently after acquiring $50 million in Bitcoin. Between May 13 and May 22, the company’s Bitcoin holdings have ballooned in value to around $474.4 million, placing Semler among the top 13 companies in the BTC finance sector.
A disclosure from May 23 indicated that Semler bought 455 BTC at an average cost of $109,801 each. The funds for this investment emerged from revenues generated by their inventory product program. To date, the firm has sold about 3 million shares of common stock, which netted approximately $115 million.
Interestingly, on the same day the disclosure was made, Semler’s stock dropped by 1.36%. However, this drop aligned closely with NASDAQ’s overall trend, as the index fell by 1%—most likely influenced by the performance of major tech stocks.
In a revenue report released on May 13 for the first quarter of 2025, Semler noted a significant 44% decline in revenue compared to the prior year. Furthermore, data from Google Finance showed that Semler’s stock had plummeted by 18% in 2025.
The landscape of Bitcoin finance has attracted investors keen on capitalizing on Bitcoin’s price volatility. Companies like Semler, which traditionally sell stocks or issue debts to invest in BTC, have piqued interest over time.
Interestingly, Michael Saylor introduced the BTC Reserve strategy back in August 2020 when he began acquiring Bitcoin. Since then, Bitcoin has soared by 181.6% annually, while Semler’s shares have seen a more modest increase of 53% since the company announced its BTC strategy in May 2024.
